NCT04818294

Brief Summary

The Treatment Cabin 'Elosan cabin' is a closed, electrically insulated cabin for the short-term application of a high electrostatic voltage to the body of patients with chronic pain. Patients assigned will have 8 sessions in the treatment cabin, with an interval of 6 days between sessions. The existing therapies and painkillers will be continued at the discretion of the doctor.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2021

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

January 26, 2023

Status Verified

January 1, 2023

Enrollment Period

1.2 years

First QC Date

March 19, 2021

Last Update Submit

January 25, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Pain Intensity is being assessed by Visual Analogue Scale (VAS)

    Change of Pain Intensity is being assessed on a horizontal 100 mm VAS (Visual Analogue Scale) pain scale. The total range of this scale is 100 mm. Minimum score is 0 mm, Maximum score is 100 mm. The higher values represent a higher intensity of pain. The values at baseline will be compared to the values at Visit 8 and the mean of the differences will be compared between the 2 treatment arms.

    8-9 weeks

Secondary Outcomes (2)

  • Composite outcome physical health (PCS) and mental health (MCS) to determine the quality of life assessed by the SF-12 Questionnaire

    8-9 weeks

  • Pain medication / therapy and any changes thereof shall be recorded during the study.

    8-9 weeks

Other Outcomes (1)

  • Improving the quality of sleep

    8-9 weeks

Interventions

Study Type is Observational as participants in the study receive therapeutic interventions in the therapy cabin as part of routine medical care and a researcher studies the effect of the intervention. The study includes all persons who are already receiving therapy in the mentioned facilities, no external, specifically selected persons, but existing patients suffering from chronic pain who meet the specified conditions. The therapy aims to alleviate chronic pain by applying an electrostatic charge of 50'000 Volt to the whole body in the special, electrically insulated cabin. The treatment is done upon the instructions of a physician. It is done with the patient standing up in the treatment cabin. The person is charged and discharged several times over the course of 2x 4 minutes. The charge can be felt on the skin and it can be seen through bristling of the hairs on the body. This treatment is repeated once a week.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will include pain patients who are already being treated in the practice of clinical or resident pain therapy facilities.

You may qualify if:

  • Informed Consent
  • adults, age ≥ 18 years, male or female patients
  • History of pain ≥ 3 months
  • Suffering from chronic pain
  • Intensity of pain rated ≥ 50 mm on VAS pain

You may not qualify if:

  • Patients with an electrical or electronic implant.
  • Women who are pregnant, breastfeeding or planning to become pregnant
  • Patients who have already been treated with the cabin within the last 4 weeks.
  • Patients who are currently participating in other studies or who have participated in other studies in the last 30 days
  • Patients who have indicated their intention or who are suspected of intending to discontinue or discontinue therapy before the end of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Centro Ortho-Bio-Med

Roveredo, CH, 6535, Switzerland

Location

Zentrum für Neurochirurgie Hirslanden Ostschweiz

Sankt Gallen, CH, 9016, Switzerland

Location

Medizinisches Zentrum

Bad Ragaz, 7310, Switzerland

Location

Spital Emmental, Schmerzzentrum

Burgdorf, 3400, Switzerland

Location

Rheumapraxis Cham Zug

Cham, 6330, Switzerland

Location

Praxis Dr. Kessler

Lucerne, 6006, Switzerland

Location

Orthopädische Schmerztherapie Zürich

Zurich, 8003, Switzerland

Location

Schulthess Klinik Zürich

Zurich, 8063, Switzerland

Location

Related Publications (1)

  • Steinhauser S, Ganter MT, Stadelmann V, Hofer CK; ELES Study Group. Whole-Body Electrostatic Pain Treatment in Adults with Chronic Pain: A Prospective Multicentric Observational Clinical Trial. Pain Ther. 2024 Feb;13(1):69-85. doi: 10.1007/s40122-023-00560-8. Epub 2023 Nov 28.

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stephan Steinhauser, M.D.

    Stadtspital Triemli, 8063 Zürich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 26, 2021

Study Start

March 16, 2021

Primary Completion

May 15, 2022

Study Completion

June 15, 2022

Last Updated

January 26, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations